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The incidence of pulmonary neoplasms discovered
by serial computed tomography scanning after
endovascular abdominal aortic aneurysm repair
Nancy L. Harthun, MD, MS,a and Christine L. Lau, MD,b Baltimore, Md; and Charlottesville, Va
Objectives: Serial computed tomography (CT) scanning is routinely used to follow up endovascular exclusion of
abdominal aortic aneurysms (AAAs). Nonvascular diseases can be identified, and these exams include images of the lung
bases, which can provide information that leads to the diagnosis of pulmonary neoplasms. This study was conducted to
determine the rate and type of pulmonary-based oncologic diseases identified by serial CT scanning of patients with
endovascular repair of AAAs.
Methods:A retrospective review of 138 consecutive patients receiving endovascular AAA exclusion during an 8-year period
was performed. Length of follow-up and number of CT scans performed was recorded. CT characteristics of the lesion
(size, character, and suspicion of malignancy), type of biopsy procedure performed, and final pathologic diagnosis were
collected. Oncologic treatments and survival length were also evaluated.
Results: Pulmonary lesions were found in 25 patients (18%), of whom 5 (4%) died during follow-up, and 13 (9%) had
stable, subcentimeter lesions and continue to have surveillance from vascular specialists only. Seven patients (5%) with
pulmonary lesions were referred for evaluation by thoracic surgeons. Six patients (4%) underwent biopsy of the lesion and
were diagnosed with cancer. One patient refused a biopsy and is being monitored with serial CT scans. Four lung cancers
(1 small cell and 3 non-small cell), one primary pulmonary carcinoid tumor, and one B-cell lymphoma were discovered.
No changes were noted in the lesions in the patient receiving CT surveillance. More than half of the cancers were
diagnosed in stage I, with a mean lesion diameter of 11 mm at biopsy. Of 25 patients with pulmonary nodules, 24 were
men. The patients diagnosed with cancer are all still alive, with a mean survival length of 2.5 years (range, 0.5-6 years)
after oncologic treatment.
Conclusions: Serial CT scans may reveal a high rate of pulmonary malignancies in a population with AAAs. Attention to
the incidental finding of pulmonary nodules on CT scans and arrangement of appropriate follow-up by the vascular
surgeon is important for patients undergoing surveillance after endovascular AAA repair. These results indicate that
aggressive management of these lesions (early thoracic surgery consultation and biopsy) is appropriate in this high-risk
population and may offer early diagnosis and improved long-term survival. ( J Vasc Surg 2011;53:738-41.)
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iEndovascular exclusion of abdominal aortic aneurysms
(AAAs) became widespread in 1999 in the United States
after Food andDrug Administration approval of devices for
this procedure. Surveillance of the AAA after placement of
these devices is mandatory due to the frequent need for
subsequent procedures, which is reported as high as 8.7% at
an average of 12 months of follow-up in some series.1-3
This surveillance can be accomplished with several different
imaging modalities, and computed tomography (CT) and
ultrasound (US) imaging are the most commonly used.
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738CT scanning exposes the patient to the risk of intrave-
ous access, iodinated contrast, and radiation exposure, but
llows the identification of endoleaks. The superiority of
T to US imaging has been debated and is currently
ontroversial.4-7 Annual CT scans are obtained in patients
ho do not have endoleaks, but 6-month intervals are
ndicated if a patient has an endoleak. CT scans expose the
atient to significant radiation, and patients with stable
ndoleaks can be subjected to 8 to 10 CT scans in a 4-year
ollow-up term.8
Many patients with endovascular exclusion of AAAs are
onitored for years by the vascular specialist who im-
lanted the devices. The specialist ordering the images is
esponsible for communicating findings to the patient and
ppropriate disposition of all abnormalities identified. Ap-
ropriate follow-up or investigation of incidental lesions
hould be organized. These responsibilities can be difficult
o manage in a system not designed for long-term
ollow-up of potential malignancies.
There are known associations between the incidence
f AAAs and pulmonary disease, specifically chronic ob-
tructive pulmonary disease9 and lung cancer.10 The
easons for this are not completely clear. Cigarette smok-
ng is a primary risk factor in both diseases and may
xplain this association completely. However, there may
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Volume 53, Number 3 Harthun and Lau 739be other related risk factors that have not been identified.
Anticipating an association between AAAs and lung can-
cers is reasonable.
We sought to determine the incidence of pulmonary
malignancy identified by CT scanning during long-term
follow-up of endovascular repair of AAAs in consecutive
patients treated at a single institution. The number of CTs
each patient was exposed to, the length of follow-up, and
the timing of the diagnosis of pulmonary diseases were
evaluated. The type of cancer and survival after oncologic
treatment was also examined.
METHODS
A database including all patients with AAAs treated
with endovascular exclusion was created. Data concerning
145 consecutive patients treated by a single surgeon be-
tween 2001 and 2009 were collected from the database,
which was approved by the University of Virginia Human
Investigation Committee (#12020). A single surgeon’s
patients were used because the approach to pulmonary
lesions described in this study was uniformly applied. The
138 patients who had at least one appointment for fol-
low-up and a CT scan at that appointment were evaluated.
All CT scan reports obtained for endograft surveillance
were reviewed for identification and characterization of
pulmonary lesions by the reviewing radiologist.
CT scans of the chest were obtained in 22 visits to
evaluate high-risk patients for thoracic aortic aneurysms. All
other CT scans were performed of the abdomen and pelvis
only. The number of CT scans per patient and length of
follow-up were tabulated. Patients with pulmonary lesions
on a preoperative CT scan were excluded if these lesions
were8mm, were spiculated or lacked calcification, or had
grown on serial imaging. Three patients had a history of
lung cancer before AAA repair, or their AAAwas discovered
during evaluation for treatment of lung cancer. These three
patients were also excluded. Patients with small (8 mm)
lesions that did not have worrisome characteristics were
included and monitored in the same manner that patients
who had no pulmonary lesions on preoperative CT scan
were.
We defined lesions that were concerning for malig-
nancy as large (8 mm), enlarging, or with suspicious
characteristics, including spiculation, lack of calcification,
or a new lesion when previous comparison imaging was
available.11 Smoking history was also collected and re-
corded as current, former, or nonsmoker. Pack-years were
recorded for those with a smoking history.
RESULTS
After the 145 patients underwent endovascular AAA
repair, 138 patients (117 men [85%]) had at least one
follow-up appointment that included a CT scan and were
included in this analysis. Patients were followed up for an
average of 2 years (265 years for 138 patients). An average
of three CT scans per patient were obtained during this
interval (439 CT scans). tOnly 7 of the 138 patients had no history of smoking
5%). Current (35 [25%]) and former (86 [62%]) smokers
ade up most of this population. Smoking history was not
ecorded for 10 patients. The smokers had a combined
619 pack-years (46 pack-years/patient). Pulmonary le-
ions were identified in 25 patients (18%) on chest (n  1)
nd abdominal/pelvic (n  24) CT, of whom 24 (96%)
ere men.
Five patients (4%) with lesions 8 mm died of unre-
ated causes (pneumonia, chronic obstructive pulmonary
isease exacerbation, colon cancer, sudden death, and
troke) during follow-up before investigation of the pulmo-
ary lesions was indicated. Thirteen patients (9%) had
table lesions that measured 8 mm and continue to re-
eive surveillance for both their AAA and pulmonary nod-
le. Patient results are summarized in the Fig.
Seven patients (5%) with pulmonary lesions were
eferred for evaluation by thoracic surgeons. Six patients
4%) underwent biopsy of their lesions and were diag-
osed with cancer. One patient refused biopsy and is
eing monitored with serial CT scans. Four lung cancers
1 small cell and 3 non-small cell), one primary pulmo-
ary carcinoid tumor, and one B-cell lymphoma were
iscovered. No changes have been noted in the lesions in
he patient receiving CT surveillance. More than half of
ig. Flow diagram of the patients in the study shows the results of
omputed tomography scans, pulmonary biopsy specimen analysis,
nd treatments administered to seven patients referred to thoracic
urgery.he cancers were diagnosed in stage I, with a mean lesion
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with cancer are all still alive, with a mean survival length
of 2.5 years (range, 0.5-6 years) after oncologic treat-
ment. Outcomes of patients referred for thoracic surgical
evaluation are summarized in the Table.
DISCUSSION
A high proportion (4% of 138) of AAA patients devel-
oped a pulmonary malignancy in long-term follow-up di-
agnosed by CT scan. This is similar to the number of
patients that may develop a thoracic aneurysm in the same
time interval and certainly deserves the attention of the
caregiver supervising this long-term surveillance. Frequent
CT scans afford the ability to determine worrisome charac-
teristics of pulmonary lesions before the lesions become
large enough to change the staging of a cancer. Two
previous studies demonstrate the benefit of CT scanning
for finding and treating early, incidental lesions.12,13 Early
diagnosis was attained for most of the patients who devel-
oped a malignancy in this population, and all of these
patients are still alive. In particular, the patient who was
found to have small cell cancer and has survived 6 years after
treatment for that disease is notable. AAA development is
highly associated with cigarette smoking. Lung cancers are
similarly highly associated with this risk factor. That pa-
tients may develop both of these problems may be ex-
plained by this shared risk factor.
The improved resolution of CT imaging demonstrates
small lesions in many organ systems, and incidental findings
requiring some type of follow-up are identified frequently.
This study was designed to take the first step to assess the
magnitude of this concern in one organ system for a specific
population frequently monitored with multiple CT scans.
This report is limited by the retrospective design and the
Table. Results of computed tomography (CT) scans, pulm
to seven patients referred to thoracic surgery
Patient
Length of
AAA
follow-up
(years)
CTs obtained
during
AAA follow-up
(No.)
Lesion
characteristics
on CT
Lesion
size
(mm) B
1 3 5 Growth 9 Y
2 6 4 Growth 11 Ye
3 1 2 Size 11 Ye
4 1 2 Growth 19 Ye
5 2 2 New 18 Ye
6 4 3 Growth 50 Ye
7 2 4 Multiple nodules 7 R
Average
(range)
2.86 (1-6) 3.14 (2-5) 5/7 growth 11.86 6/
AAA,Abdominal aortic aneurysm; LLL, left lower lobe;NA, not applicable;Ninstitutional and geographic limitations of the patient pop- slation and will need corroboration from future studies. In
ddition, information regarding the number of CT scans
btained for these patients during AAA surveillance before
AA repair and the number of CT scans obtained for other
easons is not available. Therefore, no conclusions can be
ade about total radiation exposure from CT scanning
rom this study.
CT scanning may play a role in causing lung cancers.
errington de Gonzalez et al14 recently published projec-
ions for increasing the rate of cancers by increasing the rate
f CT scan usage in the United States. These projections
re organ-specific and raise the question of whether the CT
cans may contribute to cancer formation. They project
hat the highest increase in cancers resulting from rapidly
ncreasing use of CT scanning will be in lung cancer in
omen between the ages of 45 and 85 years because of
canning of the abdomen and pelvis, and that the overall
ncrease in malignancies will be 29,000 for all CTs per-
ormed in 2007.14
Vascular surgeons monitoring patients with CT scans
eed to be attentive to incidental findings that are identi-
ed, especially pulmonary nodules, because this may repre-
ent an early malignancy. Small pulmonary lesions are typ-
cally categorized as clinically indeterminate and do not
ecessitate direct communication from the radiologist to
he ordering physician, so review of formal CT reports is
eeded. There are many alternatives for the vascular spe-
ialist when deciding the appropriate follow-up for pulmo-
ary lesions. Conveying these findings to the patient’s
rimary care provider and asking him or her to arrange a
eferral to a pulmonary specialist or to provide the
ollow-up is appropriate. Direct referral to a pulmonary
pecialist is another option.
We prefer to make direct a referral to the thoracic
ry biopsy specimen analysis, and treatments administered
Pathology Stage Treatment
Length of time
after pulmonary
diagnosis
(years)
Carcinoid I LLL wedge
resection
2
Small cell
cancer
Limited RLL resection
chemotherapy,
radiation
6
B-cell
lymphoma
IV RUL resection,
chemotherapy
6
NSCLC I RUL resection,
chemotherapy
1
NSCLC I RLL resection 2
NSCLC II RLL resection 0.5
None NA None NA
s 4/7 NSCLC 4/7 stage I 6/7 resection 2.5
3/7 chemotherapy
1/7 radiation
C, non-small cell lung cancer;RLL, right lower lobe;RUL, right upper lobe.ona
iopsy
es
s
s
s
s
s
efused
7 yeurgeons at our institution because this approach has sim-
11
1
1
1
1
1
1
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follow-up would be forgotten between the vascular special-
ist and the primary care provider. In addition, the number
and type of CT scans could be minimized and still provide
the information needed for appropriate care of both the
AAA and the pulmonary lesion.
Failure to communicate abnormal imaging findings to
patients and failure to arrange appropriate care of incidental
findings is a major source of litigation.15 Owing to the
growing awareness of this fault in the current medical
system, radiologists debate the need to communicate these
types of findings directly to the patient.16,17
CONCLUSIONS
Future research will need to corroborate the high rate
of pulmonary malignancy seen in the population described
in this study. It is unclear whether CT scans may benefit this
population by identifying early lung cancers or put them at
risk because of the possibility that radiation administered to
patients through multiple CT scans may contribute to the
formation of these cancers. Alternative imaging modalities,
especially US imaging, may be used to avoid this radiation
exposure.
The authors recognize Sandra Burks of the Surgical
Therapeutic Advancement Center at the University of Vir-
ginia for assistance in securing IRB approval for this study.
AUTHOR CONTRIBUTIONS
Conception and design: NH, CL
Analysis and interpretation: NH, CL
Data collection: NH, CL
Writing the article: NH, CL
Critical revision of the article: NH,CL
Final approval of the article: NH, CL
Statistical analysis: Not applicable
Obtained funding: Not applicable
Overall responsibility: NH
REFERENCES
1. Hong C, Heiken JP, Sicard GA, Pilgram TK, Bae KT. Clinical signifi-
cance of endoleak detected on follow-up CT after endovascular repair of
abdominal aortic aneurysm. AJR Am J Roentgenol 2008;191:808-13.
2. Hobo R, Buth J. Secondary interventions following endovascular ab-
dominal aortic aneurysm repair using current endografts. A Eurostar
report. J Vasc Surg 2006;43:896-902. S
raphy obtained to rule out pulmonary embolism. These scans
i
r
n
d
o
f
q
t3. DeBruin JL, Baas AF, Buth J, Prinssen M, Verhoeven ELG, Cuypers
PWM, et al. Long-term outcome of open or endovascular repair of
abdominal aortic aneurysm. N Engl J Med 2010;362:1881-9.
4. Golzarian J, Dussaussois L, Abada HT, Gevnois PA, Gansbeke DV,
Ferreira J, et al. Helical CT of aorta after endoluminal stent-graft
therapy: value of biphasic acquisition. AJR Am J Roentgenol 1998;171:
329-31.
5. Rozenblit AM, Patlas M, Rosenbaum AT, Okhi T, Veith FJ, Laks MP,
et al. Detection of endoleaks after endovascular repair of abdominal
aortic aneurysm: value of unenhanced and delayed helical CT acquisi-
tions. Radiology 2003;227:426-33.
6. Gorich J, Rilinger N, Sokiranski R, Soldner J, Kaiser W, Kramer S, et al.
Endoleaks after endovascular repair of aortic aneurysm: are they predict-
able? Initial results. Radiology 2001;218:477-80.
7. Chaer RA, Gushchin A, Rhee R, Marone L, Cho JS, Leers S, et al.
Duplex ultrasound as the sole long-term surveillance method post-
endovascular aneurysm repair: a safe alternative for stable aneurysms.
J Vasc Surg 2009;49:845-50.
8. Chuter TAM, Gordon RL, Reilly LM, Kerlan RK, Sawhney R, Jean-
Claude J, et al. Abdominal aortic aneurysm in high-risk patients:
short-to intermediate-term results of endovascular repair. Radiology
1999;210:361-5.
9. Spencer C, Jamrozik K, Kelly S, Bremner P, Norman P. Is there an
association between chronic lung disease and abdominal aortic aneu-
rysm expansion? ANZ J Surg 2003;73:787-9.
0. Blochle R, Lall P, Cherr GS, Harris LM, Dryjski ML, Hsu HK, et al.
Management of patients with concomitant lung cancer and abdominal
aortic aneurysm. Am J Surg 2008;196:697-702.
1. MacMahon H, Austin JHM, Gamsu G, Herold CJ, Jett JR, Naidich
DP, et al. Guidelines for management of small pulmonary nodules
detected on CT scans: a statement from the Fleischner Society. Radiol-
ogy 2005;237:395-400.
2. McDougal JL, Valentine RJ, Josephs S, Trimmer C, Clagett GP,
Modrall JG. Computed tomographic angiography has added value in
patients with vascular disease. J Vasc Surg 2006;44:998-1001.
3. Indes JE, Lipsitz EC, Veith FJ, Gargiulo NJ III, Privrat AI, Eisdorfer J,
et al. Incidence and significance of nonaneurysmal-related computed
tomography scan findings in patients undergoing endovascular aortic
aneurysm repair. J Vasc Surg 2008;48:286-90.
4. Berrington deGonzalez A,MaheshM, KimKP, BhargavanM, Lewis R,
Mettler F, et al. Projected cancer risks from computed tomographic
scans performed in the United States in 2007. Arch Int Med 2009;169:
2071-7.
5. Casalino LP, Dunham D, Chin MH, Bielang R, Kistner EO, Karrison
TG, et al. Frequency of failure to inform patients of clinically significant
outpatient test results. Arch Intern Med 2009;169:1123-9.
6. Berlin L. Using an automated coding and review process to communi-
cate critical radiologic findings: one way to skin a cat. AJR Am J
Roentgenol 2005;185:840-3.
7. Berquist TH. Communication: the needs of the patient come first. AJR
Am J Roentgenol 2009;192:557-9.ubmitted Jun 16, 2010; accepted Sep 15, 2010.INVITED COMMENTARYScott S. Berman, MD, Tucson, Ariz
The article by Harthun and Lau raises a number of cogent
points for vascular specialists who perform the endovascular
aneurysm repair (EVAR) procedure. Given the risk profile of
aortic aneurysm patients, particularly tobacco abuse, one should
not be surprised by the occurrence of pulmonary pathology on
routine computed tomography (CT) imaging that includes the
base of the lungs. The more common scenario seen today is the
incidental pulmonary nodule found on pulmonary CT angiog-nclude the full lung fields in the examination and similarly
eport a 10% to 15% overall incidence of incidental pulmonary
odules.
Themanagement pathway of the incidental pulmonary nodule
iscovered on EVAR follow-up CT is the most contentious point
f their article.Which of the patient’s care providers are responsible
or informing the patient of the finding and coordinating subse-
uent follow-up of the nodule is a discussion beyond the scope of
his commentary and has significant medical and legal implications.
